Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Innovent Biologics, Inc. is a premier biopharmaceutical company established in 2011, dedicated to developing, manufacturing, and commercializing high-quality, innovative medicines for the treatment of oncology, autoimmune disorders, metabolic diseases, ophthalmic conditions, and other significant therapeutic areas. With a mission to make groundbreaking biopharmaceutical drugs affordable and accessible to patients worldwide, Innovent has built a fully-integrated platform encompassing R&D, manufacturing, and commercialization. The company has a robust pipeline of biologic drugs and has successfully launched multiple products, establishing a strong presence in China's biopharmaceutical market with expanding global reach.
Serves as the central hub for global R&D, large-scale biopharmaceutical manufacturing, and corporate operations.
State-of-the-art research laboratories and extensive cGMP-compliant manufacturing facilities capable of producing a diverse portfolio of biologic drugs. The campus is strategically located in Suzhou BioBAY, one of China's leading biotechnology innovation parks.
A dynamic and innovative work environment driven by scientific excellence, collaboration, and a strong commitment to patient well-being. The culture fosters continuous learning and development in the pursuit of breakthrough therapies.
The Suzhou headquarters is critical to Innovent's 'end-to-end' capabilities, from discovery and development through to commercial-scale production, underpinning its rapid growth and contribution to China's biopharmaceutical industry.
Innovent Biologics supports a range of functions globally, primarily focused on research and development, clinical trials across multiple countries (including China, USA, Australia and others), and strategic partnerships for co-development and commercialization. While its manufacturing and core commercial operations are currently centered in China, the company is actively expanding its global footprint through international clinical studies and collaborations with global pharmaceutical companies to bring its innovative therapies to patients worldwide.
168 Dongping Street, Suzhou Industrial Park
Suzhou
Jiangsu Province
China
Address: 9700 Great Seneca Highway, Suite 123, Rockville, MD 20850, USA
Supports North American clinical operations and engagement with regulatory bodies like the FDA.
Address: Specific address not publicly listed, but a significant operational presence.
Manages critical aspects of drug development and commercialization for the important Northern China market and national-level regulatory interactions.
Address: Specific address not publicly listed, but a significant operational presence.
Drives commercial strategy and execution in Eastern China, a major economic and healthcare hub, and fosters strategic partnerships.
Address: Level 54, Hopewell Centre, 183 Queen’s Road East, Hong Kong
Serves as a key interface with the international financial community and supports corporate governance.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Innovent Biologics' leadership includes:
Innovent Biologics has been backed by several prominent investors over the years, including:
Innovent Biologics has maintained a stable core executive leadership team over the past 12 months, with no major publicly announced hires or departures among its top-tier executives (CEO, President, CFO, Head of R&D). The company's leadership continuity supports its ongoing strategic initiatives and growth.
Discover the tools Innovent Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Innovent Biologics likely utilizes common corporate email formats. Based on typical conventions for companies of its size and structure, a probable format would involve a combination of the employee's first and last name with the company domain.
[firstinitial][lastname]@innoventbio.com or [first].[last]@innoventbio.com
Format
jdoe@innoventbio.com or jane.doe@innoventbio.com
Example
75%
Success rate
Innovent Biologics Press Release • April 29, 2024
Innovent presented updated positive results from the Phase 3 HARMONi-A study of its PD-1/LAG-3 bispecific antibody, IBI344 (sintilimab-LAG-3), in combination with chemotherapy for first-line treatment of squamous non-small cell lung cancer (NSCLC). The findings were featured in a Presidential Symposium at the IASLC 2024 World Conference on Lung Cancer....more
Innovent Biologics Press Release • March 26, 2024
Innovent reported its financial results for the full year 2023, highlighting significant revenue growth driven by its product portfolio, advancements in its R&D pipeline with multiple clinical milestones, and continued expansion of its commercial capabilities. The company emphasized its strategic focus on innovation and global development....more
Innovent Biologics Press Release • May 15, 2024
Innovent announced the first patient has been dosed in a Phase 1 clinical trial in China for IBI389, a Claudin18.2/CD3 bispecific T-cell engaging antibody, for the treatment of patients with advanced solid tumors. This marks another step in expanding their oncology pipeline....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Innovent Biologics, are just a search away.